Skip to content
Disclosery

EXANE DERIVATIVES: SPY position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SPY, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 23,297 SPY shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 23,297 shares
    Change vs previous 13F -6,206 shares

    5.05% of the 13F portfolio, value $8,786,856.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 29,503 shares
    Change vs previous 13F +3,758 shares

    3.75% of the 13F portfolio, value $13,323,731.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 25,745 shares
    Change vs previous 13F +15,904 shares

    2.97% of the 13F portfolio, value $12,227,235.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 9,841 shares
    Change vs previous 13F -336 shares

    1.05% of the 13F portfolio, value $4,222,957.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 10,177 shares
    Change vs previous 13F +4,142 shares

    1.04% of the 13F portfolio, value $4,432,862.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 6,035 shares
    Change vs previous 13F -2,499 shares

    0.72% of the 13F portfolio, value $2,391,706.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 8,534 shares
    Change vs previous 13F +6,563 shares

    0.97% of the 13F portfolio, value $3,190,492.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,971 shares
    Change vs previous 13F not available

    0.22% of the 13F portfolio, value $660,041.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).